Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Nutanix ( (NTNX) ) has issued an announcement.
On September 17, 2025, Nutanix appointed Greg Lavender to its Board of Directors, recognizing his extensive experience in software, cloud, AI, and enterprise infrastructure. Lavender, who previously served as CTO at Intel and held senior roles at VMware, Cisco, and Citigroup, brings valuable expertise in technology strategy and innovation to Nutanix. His appointment is expected to enhance Nutanix’s strategic positioning in the enterprise technology sector, particularly in advancing its multicloud and AI capabilities.
The most recent analyst rating on (NTNX) stock is a Hold with a $81.00 price target. To see the full list of analyst forecasts on Nutanix stock, see the NTNX Stock Forecast page.
Spark’s Take on NTNX Stock
According to Spark, TipRanks’ AI Analyst, NTNX is a Neutral.
Nutanix’s strong revenue growth and strategic advancements in AI and cloud capabilities are significant strengths. However, financial stability concerns due to negative equity and high leverage, coupled with a high P/E ratio, present risks. The positive earnings call and strategic partnerships enhance the outlook, but challenges in the federal sector and retention metrics need monitoring.
To see Spark’s full report on NTNX stock, click here.
More about Nutanix
Nutanix is a leader in hybrid multicloud computing, offering a unified software platform for running applications and AI and managing data anywhere. The company helps organizations simplify operations for both traditional and modern applications, empowering digital transformation and supporting hybrid multicloud environments for over 29,000 customers worldwide.
Average Trading Volume: 2,932,498
Technical Sentiment Signal: Buy
Current Market Cap: $20.82B
For a thorough assessment of NTNX stock, go to TipRanks’ Stock Analysis page.

